Top Markets
#1 Merlin's Seal BTC Merlin's Seal BTC +42.07%
#2 0G 0G +32.62%
#3 Zora Zora +21.70%
#4 Nockchain Nockchain +19.74%
#5 Fake World Assets Fake World Assets +19.23%
#6 Notcoin Notcoin +18.05%
#7 Full Moon Full Moon +17.17%
#8 Axelar Axelar +16.37%
#9 VVS Finance VVS Finance +15.88%
#10 ADO Protocol ADO Protocol +15.63%
Coin of the day
Merlin's Seal BTC Merlin's Seal BTC
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Ocumension Therapeutics Ocumension Therapeutics

Ocumension Therapeutics

1477
Classificação em ações #12971
Based in the People's Republic of China, Ocumension Therapeutics functions as a... Based in the People's Republic of China, Ocumension Therapeutics functions as a dedicated ophthalmic pharmaceutical platform. This company, along with its subsidiaries, is committed to the research, progression, and market introduction of therapeutic solutions for individuals with various eye conditions. Its extensive product offerings target treatments for disorders such as blepharitis, infectious and allergic conjunctivitis, dry eye syndrome, cataracts, glaucoma, ocular hypertension, post-surgical inflammation, uveitis, retinitis pigmentosa, age-related macular degeneration, corneal graft rejection, myopia, and optic neuritis. By December 31, 2021, Ocumension Therapeutics boasted a pipeline of 20 drug assets. The company, founded in 2017, maintains its headquarters in Suzhou, China.
Preço da ação
$0.66137861
Valor de mercado
$531.70M
Variação (1 dia)
-2.45%
Variação (1 ano)
-42.12%
País
CN
Negociar Ocumension Therapeutics (1477)

Categoria

Healthcare
Receita da Ocumension Therapeutics (1477)
Receita em Aug 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Ocumension Therapeutics, a receita atual da empresa (TTM) é 0. Em 2026, a empresa obteve uma receita de 0 igual a a receita do ano 2026, que foi de 0. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Ocumension Therapeutics de 2026 a 2026
Receita no final de cada ano
Ano Receita Alterar
Não há dados suficientes para as datas fornecidas.
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH